Chinese patent officials visit Allied Biotechnology headquarters.

IRVINE, Calif.--(BW HealthWire)--June 25, 1997--A delegation of patent officials from the Peoples' Republic of China visited Allied Biotechnology International Inc.'s (OTC BB:ADBI) headquarters in Irvine last week (Tuesday, June 10, 1997) to exchange views on the challenges raised by the accelerating pace of technological change in the biopharmaceutical industry.

The group was accompanied by Jin Tong Chao, China's counselor general in Los Angeles.

During the visit, Ming Tinghua, the deputy commissioner of the patent office in Beijing, who led the delegation, commented that "it is important that patents be internationally recognized and that the rules for establishing patents be harmonized among countries, especially China and the United States."

"The future of our company lies in taking our technologies to Asia and the rest of the world," said Dr. Henry J. Smith, ADBI president and chief executive officer. "This meeting was an important step in developing strong ties to China."

The delegation spent a week visiting important businesses in southern California before returning to China June 13. Their trip was arranged by FCC Group International Inc. of El Monte, Calif.

ADBI is currently in discussions with governmental representatives in Mexico, Panama, Poland, Indonesia, Thailand and Canada about sales of the company's medical products in those countries. -0-

Corporate advertising and public relations handled by Corporate Imaging. -0-

NOTE TO EDITORS: Information herein was derived from sources believed to be reliable. No assurance can be made that the information is accurate.

CONTACT: Corporate Imaging Inc., Phoenix

Neil Rand, 602/504-9230

Fax: [phone]